1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow SCLC: new trials by email Literature Review of SCLC trials Research Report on SCLC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer Anlotinib hydrochloride, Etoposide, Carboplatin - SCLC, Anlotinib | Phase 2 | Unknown | Shanghai Chest Hospital | 29 | 2019-05-01 | 2020-12-24 |
Carboplatin (1) · Etoposide (1) · anlotinib (1)
China (1)
Baohui Han (1)